Lannett intros generic Thorazine

Lannett is offering chlorpromazine hydrochloride tablets in dosage strengths of 10 mg, 25 mg, 50 mg, 100 mg and 200 mg.

Lannett’s product is the generic of GlaxoSmithKline’s Thorazine.

Thorazine had a market value of approximately $120 million for the 12 months ended November 2020, according to IQVIA, although actual generic market values are expected to be lower,

"Chlorpromazine hydrochloride tablets, an internally developed product, is used to treat psychotic disorders such as schizophrenia or manic-depression in adults," said Tim Crew, CEO of Lannett. "We expect chlorpromazine hydrochloride tablets will be a solid addition to our product offering, with margins above our company average."